TICKERNERD
Menu
ASPIASPIBasic Materials · Specialty Chemicals

ASPI Stock Forecast: ASP Isotopes, Inc. Price Predictions for 2026-2027

Last close, 2 Oct 2026
$2.92
+8.15% on the day

The 3 Wall Street analysts covering ASP Isotopes, Inc. hold a median 12-month price target of $13 — +345.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 4 of 100 as at 2 Oct 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$446.1M
Ticker Nerd rank
4 / 100
Median analyst target
$13
Analysts covering
3
Revenue$5.1M+327.5% y/y
Operating income−$34.2M
Net income−$34.0M
Free cash flow−$27.4M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−0.2%
1M
−25.7%
YTD
−45.4%
1Y
−67.5%
From 52W high
−79.2%
From 52W low
+12.3%
$3
$14
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ASPI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores ASP Isotopes, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 2 Oct 2026
4 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
54
Growth
50
Accruals
39
Revisions
25
Quality
18
Volatility
6
Value
6
Momentum
6
Issuance
5

Size (54): Smaller than most of the companies we track.

Issuance (5): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ASPI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ASPI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0$5$10$15Jan 26Apr 26Jul 26Oct 26ASPIHigh $15Median $13Low $11

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $11Median $13High $15

The green dot is the last close — the median target sits +345.2% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
14 Apr 2026Canaccord GenuityMaintainsBuy$11
4 Dec 2025Cantor FitzgeraldInitiatesOverweight—
24 Nov 2025Canaccord GenuityMaintainsBuy—
17 Sept 2025Canaccord GenuityMaintainsBuy—
21 May 2025Canaccord GenuityMaintainsBuy—
18 Oct 2024Canaccord GenuityMaintainsBuy—
4 Oct 2024Canaccord GenuityInitiatesBuy—
7 Aug 2024HC Wainwright & Co.MaintainsBuy—
17 Apr 2024HC Wainwright & Co.MaintainsBuy—
29 Feb 2024HC Wainwright & Co.MaintainsBuy—
5 Dec 2023HC Wainwright & Co.InitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ASPI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ASPI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 2 Oct 2026, ASP Isotopes, Inc. returned −67.5% against +16.2% for the S&P 500, dividends included.

ASPI vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120Jan 26Apr 26Jul 26Oct 26ASPIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ASPI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

ASP Isotopes, Inc. (ASPI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−1.4×

Cheaper than 84% of US stocks

Price / sales
14.5×

Cheaper than 11% of US stocks

Price / book
1.4×

Cheaper than 56% of US stocks

EV / EBITDA
−5.1×

Cheaper than 80% of US stocks

Growth & margins
Revenue growth (YoY)
327.6%

Higher than 97% of US stocks

Earnings growth (YoY)
327.5%

Higher than 93% of US stocks

Gross margin
28.9%

Higher than 32% of US stocks

Operating margin
−667.5%

Higher than 7% of US stocks

Net margin
14.3%

Higher than 76% of US stocks

Returns & dividend
Return on equity
−90.3%

Higher than 15% of US stocks

Return on assets
−17.0%

Higher than 21% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

ASP Isotopes, Inc. (ASPI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • ASP Isotopes, Inc. has a market value of $446.1M and an enterprise value of $470.9M.

  • Revenue in the twelve months to 30 June 2026: $30.9M. The latest quarter grew 327.6% year on year.

  • Net income over the same four quarters: −$117.3M, a −380.3% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$83.6M.

  • Shares outstanding: 130.1M.

  • Trailing P/E: −1.4×; forward P/E: −4.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • ASP Isotopes, Inc. employs 271 people — $114K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 3 Oct 2026

Data provided by Twelve Data

Peers

ASPI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
ASPIASP Isotopes, Inc.$446.1M
4
ASPNAspen Aerogels, Inc.$468.6M
60
MNTKMontauk Renewables, Inc.$408.3M
49
OECOrion SA$325.1M
57
GEVOGevo, Inc.$318.9M
59
MATVMativ Holdings, Inc.$655.9M
87
ALTOAlto Ingredients, Inc.$291.6M
99

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own ASP Isotopes, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ASPI news & analysis

Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · 29 Sept 2026negative

A law firm has issued a notice advising ASP Isotopes Inc. shareholders of potential breaches of fiduciary duties by company insiders. The firm encourages shareholders to contact them about their rights and legal options at no cost, handling matters on a contingent fee basis.

Why it matters — This flags possible litigation over alleged insider fiduciary breaches, which ASPI watchers would need to monitor for legal and governance risk.

ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript

Seeking Alpha · 9 Sept 2026neutral

ASP Isotopes Inc. held an Analyst/Investor Day, the proceedings of which were published as a transcript by Seeking Alpha. The item consists of the transcript of that event.

Why it matters — A watcher of ASPI would care because the transcript provides direct insights into the company's own presentations and analyst discussion.

ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update

GlobeNewsWire · 8 Sept 2026positive

ASP Isotopes held its inaugural Capital Markets Day in London on September 8, 2026, where management outlined the company's strategy across nuclear medicine, electronics, helium and LNG, and nuclear fuels, and reviewed the building blocks supporting its long-term growth potential.

Why it matters — ASPI watchers would care because the event provides management's detailed strategic overview and growth outlook for the company's diversified critical materials businesses.

ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth

MarketBeat · 21 Aug 2026positive

ASP Isotopes CEO Paul Mann said during a conference presentation that several business units, including helium, liquefied natural gas, stable isotopes, and radiopharmaceuticals, are expected to enter commercial production or expand output over the next six months.

Why it matters — ASPI watchers would care because the company's near-term production milestones signal progress across its helium and stable isotope growth initiatives.

ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa

GlobeNewsWire · 20 Aug 2026positive

ASP Isotopes Inc. announced that Tetra4, a subsidiary of Renergen and developer of the Virginia Gas Project, has started commissioning its Phase 1 liquid helium plant in South Africa following engineering optimization. The company expects to deliver liquid helium to customers in September, ramp to nameplate capacity during the second half, and potentially advance to Phase 2 during 2H 2026.

Why it matters — The commissioning marks a key operational milestone for ASP Isotopes' helium production, potentially adding one of the first new liquid helium supplies to enter the market during a global shortage.

FAQ

Frequently asked questions about ASPI stock

What is the ASPI stock price forecast for 2026-2027?

The 3 Wall Street analysts covering ASP Isotopes, Inc. have a median 12-month price target of $13, with estimates ranging from $11 to $15. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ASPI stock a buy right now?

Of the 3 analysts covering ASP Isotopes, Inc., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks ASP Isotopes, Inc. 4 out of 100 across roughly 4,600 US stocks as at 2 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ASPI?

As at 2 Oct 2026, ASP Isotopes, Inc. ranks 4 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (54 of 100).

Will ASPI stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +345.2% from the last close, and Ticker Nerd's factor model ranks ASP Isotopes, Inc. 4 out of 100 as at 2 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ASPI stock forecast for 2030?

No analyst covering ASP Isotopes, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ASPI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $11 to $15 over the next 12 months.

How has ASPI stock performed over the past year?

ASP Isotopes, Inc. returned -67.5% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does ASP Isotopes, Inc. do?

ASP Isotopes Inc. is an advanced materials company focused on developing isotope enrichment technologies for specialized markets.

What is the latest news on ASPI?

The most recent item we track (PRNewsWire, 29 Sept 2026): "Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?". A law firm has issued a notice advising ASP Isotopes Inc. shareholders of potential breaches of fiduciary duties by company insiders. The firm encourages shareholders to contact them about their rights and legal options at no cost, handling matters on a contingent fee basis.

Company

About ASP Isotopes, Inc.

ASP Isotopes Inc. is an advanced materials company focused on developing isotope enrichment technologies for specialized markets. The company works on producing and commercializing isotopes used in nuclear medicine, semiconductors, advanced nuclear fuels, and other industrial applications. Its current business is organized around Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment is centered on technologies for high-assay low-enriched uranium and lithium-6, while the Specialist Isotopes segment targets high-value, low-volume isotopes such as carbon-14, molybdenum-100, and silicon-28. ASP Isotopes Inc. also develops related enrichment and separation processes designed to support critical materials supply chains across healthcare, energy, and technology industries. Founded in 2021 and headquartered in Dallas, Texas, ASP Isotopes Inc. is positioned as a supplier of specialized isotope products and services in niche global markets.

CEO Mr. Paul Elliot Mann C.F.A. · 271 employees · United States · https://aspisotopes.com